<

SANOFI-AVENTIS (EPA:SAN) Nirsevimab demonstrated protection against respiratory syncytial virus disease in healthy infants in Phase 3 trial

Transparency directive : regulatory news

26/04/2021 08:00



Other stories

24/04/2024 23:00
24/04/2024 22:37
24/04/2024 21:37
25/04/2024 01:48
25/04/2024 03:30
25/04/2024 08:08
24/04/2024 23:35
25/04/2024 07:29
25/04/2024 03:30
25/04/2024 02:15
24/04/2024 23:07
25/04/2024 03:05
25/04/2024 02:22
25/04/2024 00:03
25/04/2024 07:26
25/04/2024 02:48
24/04/2024 15:20
24/04/2024 18:30
24/04/2024 09:06
24/04/2024 17:45
24/04/2024 18:09
24/04/2024 14:12
24/04/2024 18:28
25/04/2024 06:00
25/04/2024 02:52
23/04/2024 14:06
25/04/2024 01:49
25/04/2024 05:00
25/04/2024 00:18
24/04/2024 23:30
24/04/2024 07:30
24/04/2024 08:05
24/04/2024 17:00
24/04/2024 03:30
24/04/2024 00:00
25/04/2024 03:28
25/04/2024 03:30
24/04/2024 09:15